CeloNova Announces Late-Breaking Evidence from First-Ever Randomized Controlled Trial …,

… duration and stent choice for high bleeding risk patients formally excluded from clinical trials,” stated Professor Robert Byrne, MB, BCh, PhD, MRCPI, …, … duration and stent choice for high bleeding risk patients formally excluded from clinical trials,” stated Professor Robert Byrne, MB, BCh, PhD, MRCPI, …, Read More